142 results
Page 3 of 8
8-K
EX-4.1
4qb8d tcj3f5amrhmxw
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.2
pjav8sxtn
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
7wh4o tqrwmz
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.3
j42guvnmv5ukp8u6
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.2
gvujukt3pa6yhv201mjg
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
hzwlb7
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
lz6nljupkya 3p9
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
8j6siv
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
rdvbjw6z 09
7 Apr 22
Prospectus supplement
4:46pm
S-3
8rca 9c000o0mzxdh
4 Feb 22
Shelf registration
4:36pm
8-K/A
EX-99.3
wv3f9wgf
22 Dec 21
Audited Financial Statements
12:00am
8-K/A
EX-99.2
l47on2la
22 Dec 21
Audited Financial Statements
12:00am
8-K/A
EX-99.1
s456l4a6p6dzs94
22 Dec 21
Audited Financial Statements
12:00am
DEF 14A
vars7aiv72c2ft
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
ix71gmpnypskuk
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm